Concurrent Chemoradiation as a Treatment Option for Advanced-Stage Laryngeal Cancers
Arch Otolaryngol Head Neck Surg. 2005;131:820.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
There is little doubt that concurrent CRT has a valuable role in the management of advanced-stage laryngeal carcinoma. The results of both the VA laryngeal trial as well as the RTOG 91-11 trial have given us great insight into the utility of CRT in the management of this disease.1-2 Enepekides has thoroughly reviewed the pertinent literature on the use of both partial laryngeal surgery and CRT for advanced-stage laryngeal carcinoma.
To establish the T classification as T3 for a patient with a laryngeal carcinoma, the findings on physical examination as well as cross-sectional imaging of the neck are required. But, many others factors unrelated to tumor stage are critical in making decisions regarding therapy. These include both functional and social issues unique to each patient. Does the patient require a tracheostomy for respiration? Does the patient aspirate with or without a history of pneumonia? Does the patient reside in an . . . [Full Text of this Article]
AUTHOR INFORMATION
Russell B. Smith, MD
Author Affiliations: Department of Otolaryngology–Head & Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City.
RELATED ARTICLES
Concurrent Chemoradiotherapy as the Most Appropriate Treatment for Most T3 Laryngeal Carcinomas
Danny J. Enepekides
Arch Otolaryngol Head Neck Surg. 2005;131(9):815-818.
EXTRACT
| FULL TEXT
Selecting From the Menu of Treatment Options for Locally Advanced Laryngeal Cancer
K. Thomas Robbins
Arch Otolaryngol Head Neck Surg. 2005;131(9):819.
EXTRACT
| FULL TEXT
|
